The 6th China Bioindustry Conference was held in Taizhou, Jiangsu. The mysterious veil of the "12th Five-Year Plan" of the bio-industry, which is waiting for the approval of the relevant authorities of the country, was resolved at the conference.
Deputy Director-General of the National Development and Reform Commission, Lian Weiliang, introduced the development status of the bio-industries during the “Eleventh Five-Year Plan†period in China and the main development goals and key tasks of the “Twelfth Five-Year Planâ€. According to reports, in the past five years, China's bio-industry has developed rapidly. The scale of bio-pharmaceuticals, bio-pesticides, etc. has rapidly expanded, and the structure has been continuously optimized. The industry has continuously emerged mergers and reorganizations, and the degree of concentration has significantly improved. A large number of large enterprises with annual sales exceeding RMB 10 billion and large batches with annual sales exceeding RMB 1 billion have emerged. Industrial investment is active, innovative companies continue to emerge, and economic benefits continue to increase.
In the “12th Five-Year Plan†period that has already arrived, China’s bio-industry has ushered in a more critical development turning point. Lien Wei Liang revealed that during the “12th Five-Year Plan†period, the demand for the development of the bio-industry is more urgent, and it is necessary to accelerate the development of new drugs and new medical equipment to meet the rapidly growing health needs.
It is reported that the key areas and major tasks of the "Planning" were first announced at the meeting.
The "Planning" proposes that according to the needs of China's economic development, by 2015, China should form a distinctive path of development of the bio-industry, and its contribution to economic development will increase significantly. In a global industrial competition, it occupies a favorable position. To lay a solid foundation for becoming a national pillar industry by 2020. To this end, China's bio-industries must form five major goals in the “Twelfth Five-Year Planâ€: more rational structure and layout, significantly enhanced innovation capacity, significant increase in scale and quality, significant improvement in the development environment, and more visible social benefits.
In order to achieve high-quality development of China's bio-industry, the "planning" also pointed out that we must focus on the development direction of the seven major industries. The first is to focus on high-quality development of bio-pharmaceuticals, enhance industrial competitiveness, comprehensively improve bio-pharmaceutical enterprise's ability to innovate and manage product quality, and develop new technologies and industrialization of chemical drugs and traditional Chinese medicines; second, it will focus on breakthroughs in the bottleneck of core components of biomedical engineering. Promote the high-end development of medical engineering equipment, diagnose and treat the needs of the health care market, such as surgery and rehabilitation; Advanced in vitro diagnostic products; Third, focus on accelerating the promotion of bio-agricultural achievements and vigorously develop the bio-breeding industry; Fourth, promote the application of green bio-technology on a large scale. The bio-manufacturing industrial system; Fifth, the development of bio-diversity; The sixth is to speed up the use of bio-environmental protection technology; The seventh is to cultivate market demand and cultivate new forms of bio-services.
It is worth noting that in order to promote the development of the bio-industry during the 12th Five-Year Plan period, in addition to organizing and implementing major action plans such as “Bio-tech Drug Development†and “Bio-breeding Innovation and Developmentâ€, “advancement of access policies†will be implemented. "Integrity system construction" "implementation of demand incentives, intensified market pull, and support innovative enterprises in market development" "Improve innovation and incentive mechanisms, such as tax incentives, establish a number of venture capital institutions for different stages, open up green channels, and encourage qualified companies The Bank will carry out bond financing, encourage financial institutions to provide financial support to the bio-industry, and guide the guarantee agencies to provide financing credit service, strengthen resource management, and establish and improve laws and regulations.
Clutch Cover Assy,Clutch Pressure Plate,Chevrolet Sail Clutch Cover,Chevrolet Sail Pressure Plate
ZHEJIANG LINGFENG TECHNICAL CO.,LTD. , https://www.boxnclutch.com